Interleukin Genetics Signs Second Employer Agreement in Pittsburgh Region
Mar 13, 2017 12:00 pm UTC| Business
WALTHAM, Mass., March 13, 2017 -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has signed an agreement with Spang Company, a...
Mar 13, 2017 11:51 am UTC| Business
Dublin, March 13, 2017 -- Research and Markets has announced the addition of the "The Global Market for High Impact Nanomaterials: Nanocellulose, Carbon Nanotubes, Graphene and 2-D Nanomaterials" report...
Mar 13, 2017 11:47 am UTC| Business
Dublin, March 13, 2017 -- Research and Markets has announced the addition of the "The Nanotechnology and Nanomaterials Global Opportunity Report (2017)" report to their offering. ...
Mar 13, 2017 11:35 am UTC| Business
DEVON, Pa., March 13, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today...
Mar 13, 2017 11:34 am UTC| Business
LONDON, March 13, 2017 -- Dr. Philip Comberg, chief executive officer and Carl Weatherley-White, chief financial officer of VivoPower International PLC (“VivoPower”) (NASDAQ:VVPR), are scheduled to present and...
ParkerVision Filing Motion to Terminate ITC Investigation Following Ruling to Disallow Key Evidence
Mar 13, 2017 11:31 am UTC| Business
JACKSONVILLE, Fla., March 13, 2017 -- ParkerVision, Inc. (Nasdaq:PRKR), a developer and marketer of semiconductor technology solutions for wireless applications, today announced that in light of a recent ruling by the...
ParkerVision Filing Motion to Terminate ITC Investigation Following Ruling to Disallow Key Evidence
Mar 13, 2017 11:31 am UTC| Business
JACKSONVILLE, Fla., March 13, 2017 -- ParkerVision, Inc. (Nasdaq:PRKR), a developer and marketer of semiconductor technology solutions for wireless applications, today announced that in light of a recent ruling by the...